Research on CLDN2 has primarily focused on gastrointestinal diseases, due to its role as a member of the tight junction protein family, prompting extensive investigation into its role about the intestinal barrier (Beggs et al., 2023; Ganapathy et al., 2023; Rini et al., 2023). This evidence concerns the gene CLDN2 and gastrointestinal disease.